Quant Healthcare Fund Direct Growth

Quant Healthcare Fund Direct Growth

NAV as on 02-04-2025

₹ 14.5

-1.4%

1D

Inception Returns

23.3%

/yr

Historical NAV & Returns

Absolute

zero opening, trading, fund transfer fee
1282 people have invested ₹ 67.7L in Quant Healthcare Fund Direct Growth in the last three months

About Quant Healthcare Fund Direct Growth

Quant Healthcare Fund Direct Growth is an equity fund. This fund was started on 18 July, 2023. The fund is managed by Sanjeev Sharma, Ankit A. Pande. The fund could potentially beat inflation in the long-run.

Key Parameters

  1. Quant Healthcare Fund Direct Growth has ₹348 Cr worth of assets under management (AUM) as on Feb 2025 and is less than category average.
  2. The fund has an expense ratio 0.8.

Returns

Quant Healthcare Fund Direct Growth has given a CAGR return of 23.27% since inception. Over the last 1 year the fund has given a CAGR return of 5.40%.

Holdings

Quant Healthcare Fund Direct Growth has allocated its funds majorly in Cash Equivalent, Health, Energy, Consumer Defensive, Tech. Its top holdings are Divi's Laboratories Ltd, RPG Life Sciences Ltd, Aster DM Healthcare Ltd Ordinary Shares, Zydus Lifesciences Ltd, Ipca Laboratories Ltd

Taxation

As it is a sector - healthcare mutual fund the taxation is as follows:
For short term (less than a year) capital gains will be taxed at 20%
For long term (more than 1 year) capital gains will be taxed at 12.5% without indexation benefit
Dividends will always be taxed at slab rate. Long term gains upto Rs 1 lakh are exempt capital gains tax.

Investment objective of Quant Healthcare Fund Direct Growth

The primary investment objective of the scheme is to provide capital appreciation by investing in equity and equity related instruments including derivatives and debt and money market instruments. However, there can be no assurance that the investment objective of the Scheme will be realized, as actual market movements may be at variance with anticipated trends.

Minimum Investment and lockin period

Minimum investment for lump sum payment is INR 5000.00 and for SIP is INR 1000.00. Quant Healthcare Fund Direct Growth has no lock in period.

Quant Healthcare Fund Direct Growth Overview

Expense ratio0.78%
Benchmark
S&P BSE Healthcare PR
AUM₹348 Cr
Inception Date18 July, 2023
Min Lumpsum/SIP₹5000/₹1000
Exit Load
1.0%
Lock InNo Lock-in
TurnOver
140.37%
STCGSelling mutual fund before 1 year, returns taxed at 20%.
LTCGAfter 1 year, 12.5% tax on returns over ₹1.25 lakh/year.
Risk
Risk meter
pointer
Very High Risk

Trailing Returns

as on (02-Apr-25)

Period
Quant Healthcare Fund Direct Growth
Nifty 500
sector - healthcare
1M
5.5%
7%
5.9%
3M
-12.7%
-6.8%
-10.6%
6M
-18.6%
-12.4%
-8.9%
1Y
5.4%
3.4%
13.4%

Fund Distribution

as on (28-Feb-25)

  • Equity 99.1%

  • Debt & Cash 0.9%

Small cap
52.3%

Large cap
31.8%

Mid cap
13.7%

Sector Allocation

Feb'25

Jan'25

Dec'24

Health
81.5%
Energy
6.9%
Consumer Defensive
5.9%
Tech
5.6%
All changes are between Dec'24 and Feb'25
Dec'24
Fund Returns
-2.89%
Nifty 500
-2.02%
Parameters
Feb'25
Jan'25
Dec'24
AUM
₹ 347.5 Cr
₹ 402.5 Cr
₹ 439.5 Cr
  • AUM of the fund stands at 347.5 Cr as of Feb'25
  • AUM decreased by 55 Cr between Feb'25 and Jan'25
Top Stocks bought last month
Divi's Laboratories Ltd's allocation increased from 8.49% to 9.67%
Divi's Laboratories Ltd's allocation increased from 8.49% to 9.67%
Ipca Laboratories Ltd's allocation increased from 6.55% to 7.13%
Ipca Laboratories Ltd's allocation increased from 6.55% to 7.13%
SMS Pharmaceuticals Ltd's allocation increased from 3.32% to 3.65%
SMS Pharmaceuticals Ltd's allocation increased from 3.32% to 3.65%
Top Stocks sold last month
RPG Life Sciences Ltd's allocation decreased from 9.28 % to 9.05 %
RPG Life Sciences Ltd's allocation decreased from 9.28 % to 9.05 %
Aster DM Healthcare Ltd Ordinary Shares's allocation decreased from 8.61 % to 8.18 %
Aster DM Healthcare Ltd Ordinary Shares's allocation decreased from 8.61 % to 8.18 %
Reliance Industries Ltd's allocation decreased from 6.87 % to 6.71 %
Reliance Industries Ltd's allocation decreased from 6.87 % to 6.71 %
Mid Cap allocation has gone up from 12.9% to 13.7%
Mid Cap allocation has gone up from 12.9% to 13.7%
Large Cap allocation has gone up from 29.2% to 31.8%
Large Cap allocation has gone up from 29.2% to 31.8%
Small Cap allocation has gone up from 52.2% to 52.3%
Small Cap allocation has gone up from 52.2% to 52.3%
Cash allocation has gone down from 1.9% to 0.9%
Cash allocation has gone down from 1.9% to 0.9%

Top 3 Sectors in February were Health, Government & Energy

Feb'25
Health
82%
Energy
7%
Consumer Defensive
6%
Jan'25
Health
81%
Government
65%
Energy
7%
Fund
Feb'25
Jan'25
Dec'24
No of Holdings
20
20
25
Top 5 Company Concentration
41.4%
40.8%
37.2%
Company having highest exposure
Divi's Laboratories Ltd (9.7%)
RPG Life Sciences Ltd (9.3%)
Aster DM Healthcare Ltd Ordinary Shares (8.5%)
No of Sectors
4
5
5
Top 5 Sectors Concentration
100%
164.7%
100%
Sector having highest exposure
Health (81.5%)
Health (80.9%)
Health (80.3%)
Loading...
We are taking more time than usual
Sanjeev Sharma
Sanjeev Sharma
Fund Manager of Quant Healthcare Fund Direct Growth, since 18 July 2023
Ankit A. Pande
Ankit A. Pande
Fund Manager of Quant Healthcare Fund Direct Growth, since 18 July 2023
Fund House
Quant Money Managers Limited
Total Schemes
Total AUM
₹90.75K Cr
as on 28-Feb-2025
Address
6th Floor, Sea Breeze Building,Appasaheb Marathe Marg, Prabhadevi
Phone
022-62955000
Website
help.investor@quant.in

Quant Healthcare Fund Direct Growth Highlights

Risk meter
pointer

Very High Risk

Investors understand that their principal will be at Very High Risk
About the fund

About the fund

This fund has delivered an average annual returns of 23.27% since inception which is more than its category average return of 16.54%
Fund Allocations

Fund Allocations

This fund has an allocation of 99.08% in Equity, 0% in Debt and 0.92% in Cash related instruments
AUM size ₹348 Cr

AUM size ₹348 Cr

This fund has AUM of ₹348 Cr which is less than its category average of ₹ 1725 Cr
Expense Ratio 0.78%

Expense Ratio 0.78%

This fund has an expense ratio of 0.78% which is less than its category average expense ratio of 1.45%

More funds from Quant

Quant Quantamental Fund Direct Growth

Quant Quantamental Fund Direct Growth

3Y CAGR

▲ 21.15

Quant Small Cap Fund Growth Option Direct Plan

Quant Small Cap Fund Growth Option Direct Plan

5Y CAGR

▲ 51.68

Quant Value Fund Direct Growth

Quant Value Fund Direct Growth

3Y CAGR

▲ 20.61

Quant Infrastructure Fund Growth Option Direct Plan

Quant Infrastructure Fund Growth Option Direct Plan

5Y CAGR

▲ 45.35

Quant Mid Cap Fund Growth Option Direct Plan

Quant Mid Cap Fund Growth Option Direct Plan

5Y CAGR

▲ 38.98

Frequently Asked Questions for Quant Healthcare Fund Direct Growth

The current NAV of Quant Healthcare Fund Direct Growth is ₹14.5 as on 02-Apr-2025.
Existing (Absolute + CAGR) as on 02-Apr-2025.
Quant Healthcare Fund Direct Growth
Absolute Returns
CAGR Returns
1 Month Returns
5.52%
5.52%
6 Month Returns
-18.63%
-18.63%
1 Year Returns
5.4%
5.4%
3 Years Returns
0%
0%
5 Years Returns
0%
0%
With INDmoney, the process of investing is very simple and involves zero commission.
  • Click Buy on the fund name.
  • Input the amount you are looking to invest.
  • Select Lump Sum or SIP (Weekly, Monthly or Quarterly).
  • Select your bank account and proceed with Payment.
0.78% as on March 2025
₹348 Cr as on March 2025
Divi's Laboratories Ltd(9.67%), RPG Life Sciences Ltd(9.05%), Aster DM Healthcare Ltd Ordinary Shares(8.18%), Zydus Lifesciences Ltd(7.39%), Ipca Laboratories Ltd(7.13%) as on March 2025
Health(80.76%), Energy(6.85%), Consumer Defensive(5.89%) as on March 2025
The alpha ratio for the Quant Healthcare Fund Direct Growth for various period is as follows:
Fund Name
Alpha 1 Year
Alpha 3 Years
Alpha 5 Years
Quant Healthcare Fund Direct Growth
-3
-
-
As on March 2025
The alpha for Quant Healthcare Fund Direct Growth is calculated against S&P BSE Healthcare PR. Higher alpha indicates that this fund has generated extra returns compared to the benchmark index. An alpha of 1.0 means the fund has outperformed its benchmark index by 1%.
The Beta ratio for the Quant Healthcare Fund Direct Growth for various period is as follows:
Fund Name
Beta 1 Year
Beta 3 Years
Beta 5 Years
Quant Healthcare Fund Direct Growth
0.88
-
-
As on March 2025
The Beta for Quant Healthcare Fund Direct Growth is calculated with S&P BSE Healthcare PR. Beta tells the volatility of the mutual fund relative to its benchmark. If the beta of a mutual fund is more than 1, then the mutual fund is more volatile than its benchmark. If beta is less than 1, then the mutual fund is less volatile than the benchmark.
The sharpe ratio for the Quant Healthcare Fund Direct Growth for various period is as follows:
Fund Name
Sharpe Ratio 1 Year
Sharpe Ratio 3 Years
Sharpe Ratio 5 Years
Quant Healthcare Fund Direct Growth
0.2
-
-
As on March 2025
The sharpe ratio for Quant Healthcare Fund Direct Growth is calculated with S&P BSE Healthcare PR. Sharpe ratio tells risk-adjusted-returns of the mutual fund. The higher a fund's Sharpe ratio, the better a fund's returns have been relative to the risk it has taken on.
The standard deviation for the Quant Healthcare Fund Direct Growth for various period is as follows:
Fund Name
Standard Deviation 1 Year
Standard Deviation 3 Years
Standard Deviation 5 Years
Quant Healthcare Fund Direct Growth
22
-
-
As on March 2025
Standard deviation tells the volatility of the returns of the mutual fund. The higher a fund's Standard deviation, the higher the volatility of the fund's returns.
Sanjeev Sharma, Ankit A. Pande are the fund managers of Quant Healthcare Fund Direct Growth
The Exit load of Quant Healthcare Fund Direct Growth is 1%